Latest Clinical trial Stories
Reaches Full Enrollment in Two Months at 15 Sites SAN DIEGO, June 2, 2015 /PRNewswire/ -- Obalon Therapeutics, Inc.
Neuroscience Company Focused on Phase 3 Development Program in Alzheimer's Disease BROOMFIELD, Colo., June 2, 2015 /PRNewswire/ --
Planned Marketing Authorization Application for Locilex® in Europe for treatment of patients with diabetic foot infection appropriate for topical therapy not expected to require any new clinical trials
-- GI Clinician and Scientist Most Recently Served in Leadership Positions at Quintiles and the U.S.
TOKYO and NORTHBROOK, Ill., June 1, 2015 /PRNewswire/ -- Astellas Pharma Inc.
Data from MM-398 Phase 1 investigator-sponsored study presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting CHICAGO, June 1, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals,
Preliminary analysis of dose-escalation portion of Phase I/II clinical trial shows increasing dose-dependent median survival in refractory GBM patients following treatment with VAL-083 VANCOUVER,
In the news release, NW Bio Announces Data to Date From DCVax®-Direct Phase I Trial, issued 01-Jun-2015 by Northwest Biotherapeutics, Inc.
DAVIE, Fla., June 1, 2015 /PRNewswire/ -- Researchers from South Florida based Nuovo Biologics LLC and
Vitesse formed to identify and advance early stage biologic research in immunology, hematology and oncology DEERFIELD, Ill., ROCHESTER, Minn.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.